Oral Proteins and Peptides Industry 2018 Market by Size, Analysis, Demand, Outlook, Demand, Regions, Top Companies and 2023 Forecast Research

in oralproteins •  6 years ago 

The Global Oral Proteins and Peptides Market by Drug Type was valued at USD XX million in 2017, and is expected to grow at a CAGR of XX% by 2025. The demand for oral peptide and protein-based therapeutics has increased significantly, owing to increase in prevalence of chronic diseases, rise in patient preference for oral drugs, and enhanced patient compliance.

Upsurge in collaboration between pharmaceutical companies for drug development and surge in prevalence of chronic diseases are the key factors that augment the growth of the global oral proteins and peptides market. Moreover, rise in geriatric population and improvement in healthcare infrastructure are expected to boost the market growth.

Get Sample copy @ https://www.orianresearch.com/request-sample/708088

High costs associated with oral peptides and proteins and low bioavailability of these drugs in the body restrict the growth of the market.

Increase in purchasing power of developing countries and rise in R&D activities by pharmaceutical companies are expected to provide new opportunities for market players in the near future.

By drug type, the global oral proteins and peptides market is divided into insulin, linaclotide, calcitonin, plecanatide, and octreotide. Among these products, insulin is expected to account for the largest share of the market. Linaclotide was the fastest growing segment in 2017 and is expected to grab the largest share of total revenue in the coming years.

By application segment, the global oral proteins and peptides market is divided into diabetes, bone diseases, hormonal disorders, gastric & digestive disorders, and others. Diabetes was the leading application segment accounting largest revenue share in 2016.

Regionally, U.S. is anticipated to generate the highest revenue in the oral proteins and peptides market in 2022. The rest of the world possesses high market potential for the growth of the market, owing to increase in awareness about oral peptide and protein therapeutics based treatment and rise in oral peptide and protein therapeutics applications. This region is anticipated to experience fast-paced growth, in terms of development and use of protein therapeutics.

Some of the key players in oral proteins and peptides market include Allergan Plc, Chiasma, Inc., Synthetic Biologics, Generex Biotechnology Corp., Proxima Concepts Limited (Diabetology Ltd.), Novo Nordisk A/S, and Tarsa Therapeutics Inc., Synergy Pharmaceuticals Inc., Sanofi S.A., Biocon Limited, F. Hoffmann-La Roche AG, AstraZeneca Plc, Inc., Hovione Limited, Novartis International AG, among others.

Key Benefits of the Report:

  • Global, Regional, Country, Type, and Packaging Market Size and Forecast from 2014-2025

  • Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies

  • Identification of key companies that can influence this market on a global and regional scale

  • Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies

  • Detailed insights on emerging regions, Type & Packaging, and competitive landscape with qualitative and quantitative information and facts

Global Oral Proteins and Peptides Industry 2018 Market Research Report is spread across 121 pages and provides exclusive vital statistics, data, information, trends and competitive landscape details in this niche sector.

Inquire more or share questions if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/708088

Target Audience:

  • Hospitals

  • Traders, Importer and Exporter

  • Raw material suppliers and distributors

  • Research and consulting firms

  • Government and research organizations

  • Associations and industry bodies

Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity production, spending were taken into consideration.

We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:

  • Original Equipment Manufacturer,

  • Type Supplier,

  • Distributors,

  • Government Body & Associations, and

  • Research Institute

  • Hospitals

Order a Copy of this Report @ https://www.orianresearch.com/checkout/708088

Table Of Content

1 Executive Summary

2 Methodology And Market Scope

3 Oral Proteins And Peptides Market By Drug Type — Industry Outlook

4 Oral Proteins And Peptides Market By Drug Type Type Outlook

5 Oral Proteins And Peptides Market By Drug Type Packaging Outlook

.Oral Proteins And Peptides Market By Drug Type Regional Outlook

7 Competitive Landscape

End Of The Report

Disclaimer

About Us

Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President – Global Sales & Partner Relations

Orian Research Consultants

US: +1 (415) 830-3727 | UK: +44 020 8144-71-27

Email: [email protected]

Website: www.orianresearch.com/

Follow Us on LinkedIn: https://www.linkedin.com/company-beta/13281002/

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!